ARCHIVES

Early HER2 Positive Patients At Higher Risk of Recurrence

This article is from The Cancer Letter archive.

Vol. 32 No. 1 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

European Compound enhances IL-2 In BRMP Mouse Study; BRMP Mouse Study; Rosemberg Describes System Improvements, Updates Results

June 5, 1987

Reimbursement: NCI, VA Begin Project On Clinical Trials Access For Veterans

January 17, 1997

BSA Strikes Down NCI Tissue Bank Plan, Calls for Audit of caBIG

March 11, 2011

Congress to hold hearings on NIH ethics, Zerhouni pledges greater transparency.

January 9, 2004

The Cancer Letter To End Print Edition In January

November 20, 2009

Waxman Compromise Bill Clears House; Centers Line Item Traded For Guarantee Of Minimum Number of 55

November 25, 1983